# Trending Content OS — Daily Run
**Run date:** 2026-10-11 | **Niche:** Health & Wellness

---

## 1. Preflight Summary

```yaml
preflight_status:
  all_sections_present: true
  missing_sections: []
  site_niche_set: true
  target_audience_set: true
  site_url_set: false
  serpapi_connected: true
  google_trends_available: true
  google_trends_tool: "serpapi_prefetch"
  search_velocity_source: "google_trends"
  active_tools: [serpapi_news, serpapi_trends, google_news_radar]
  inactive_tools: [reddit_api (not queried this run), social_search (not queried this run), content_database]
  can_run_signal_listener: true
  notes: "site_url not configured — self-check skipped; competitor-list fallback (configs/competitor_list.yaml) used for duplicate/SERP-gap context. Google Trends available via injected SerpAPI pre-fetch block — treated as primary search_velocity input. data/deferred_topics.yaml had no entries with a passed recheck_on date. Recurring-theme check against run history: mental health content and FDA recalls have each appeared in 3+ consecutive runs (10/06–10/10) — flagged below as recurring/check-for-staleness."
next_action: run_signal_listener
```

---

## 2. Google News Radar Coverage Summary

144 unique headlines across 12 queries clustered into ~13 topic groups:

| Cluster | Disposition | Reasoning |
|---|---|---|
| **Healthcare price transparency (HHS/CMS/KFF/PBS)** | Rejected — off-category | Policy/business, not a health-evidence or patient-care angle |
| **WHO community mental health shift** | Rejected — existing | Covered 10/10, no new development |
| **World Mental Health Day institutional PR flood** ([San Diego County](https://www.countynewscenter.com/mental-wellness-begins-with-a-moment-dont-wait-to-take-yours/), [Shrewsbury MA](https://shrewsburyma.gov/CivicAlerts.aspx?AID=9770), [Purdue](https://www.purdue.edu/newsroom/purduetoday/2026/Q4/explore-benefits-wellness-resources-at-wednesdays-your-path-wellness-fair), [WFU](https://inside.wfu.edu/2026/10/new-wellness-concierge-tool-supports-campus-mental-health/), [Army.mil](https://www.army.mil/article-amp/296026/ready_anywhere_how_virtual_wellness_coaching_fits_military_life), [Davenport](https://post.davenport.edu/academics/davenport-promotes-mental-wellness-during-mental-health-awareness-week/), [Utah](https://attheu.utah.edu/announcements/student-health-wellness-awarded-500000-to-advance-campus-suicide-prevention/)) | Rejected — local/institutional | Too narrow for national audience; excluded category |
| **Gilead × Calm wellness partnership** | Rejected — off-category | Pharma marketing/brand partnership, not evidence-based content |
| **AI-in-medicine cluster** ([Lancet/AMIE](https://blog.google/innovation-and-ai/technology/health/amie-clinical-study-lancet/), [NYT AI chatbot triage](https://www.nytimes.com/2026/10/08/technology/ai-chatbots-urgent-care.html), [Pew influencer studies](https://www.pewresearch.org/data-labs/2026/10/07/what-do-health-and-wellness-influencers-post-about/)) | Rejected — existing | All covered 10/07–10/09 |
| **Nobel Prize in Medicine (optogenetics)** | Rejected — existing | Covered 10/06 |
| **Heat/sauna therapy for depression** | Rejected — existing | Covered 10/06; NPR piece is same underlying story |
| **Clinical trial operations/IT news** ([Mount Sinai EHR](https://www.mountsinai.org/about/newsroom/2026/mount-sinai-tisch-cancer-center-cuts-clinical-trial-data-entry-time-by-more-than-half-with-real-time-ehr-to-edc-tech), [Ochsner AI screening](https://www.healthcareitnews.com/news/ochsner-uses-ai-widen-clinical-trial-screening), [Alpheus glioblastoma trial PR](https://www.prnewswire.com/news-releases/alpheus-medical-opens-enrollment-in-new-clinical-trial-for-butterfly-glioblastoma-302902632.html)) | Rejected — weak signal | Press-release-only, operational/B2B framing, low consumer relevance |
| **FDA recall cluster — Gatorade / eye drops / frozen blueberries** | Rejected — existing/stale | Gatorade and eye drops covered 10/06 & 10/08; blueberries page is a July 2026 investigation re-surfacing |
| **FDA recall — baby/infant sleep aid (undisclosed alcohol)** | **Rejected at Skill 02b** | Single low-tier source (NEWStalk870), no FDA.gov confirmation, no lot codes — fails breaking-recall exception (needs 3+ sources) |
| **Diet soda / Walter Willett weight-management "study"** (Trends rising query) | **Rejected at Skill 02b** | No traceable primary source found in any channel — unverifiable health claim |
| **Celebrity mental health rising searches** (Lane Johnson, Stephen A. Smith, James Talarico) | Rejected — brand safety | Speculative commentary on private individuals' mental health; no health-evidence angle |
| **USC psilocybin + mindfulness depression trial** | **Monitored (P5)** | Gate passed, but single-source (Keck News only) → low confidence, trend score below threshold |
| **Stanford gut microbiome / human migration study** | **Monitored (P5)** | Gate passed, but single-source (Stanford Medicine only) → low confidence, trend score below threshold |
| **Late-night eating & liver/metabolism study (OHSU + Health.com)** | **Retained** | Two-source convergence (institutional + health media), fresh, fits nutrition/diet science |
| **GLP-1 mechanism/side-effect explainer** (Google Trends rising queries re: Wegovy/Zepbound) | **Retained** | Search-driven evergreen opportunity, cluster-expansion of 10/04 GLP-1 pipeline coverage |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-10-11T08:00:00Z"
  run_completed_at: "2026-10-11T08:42:00Z"
  total_signals_reviewed: 153   # 144 News Radar headlines + 9 Trends keyword clusters
  total_signals_retained: 2
  total_monitored_p5: 2
  total_rejected: 30
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 4
    brand_safety: 1
    duplicate: 12
    weak_signal: 3
    unverified_claim: 2
    other: 8   # local/institutional PR not individually actionable
  highest_priority_topic: "Late-night eating linked to liver strain (OHSU study)"
  strongest_signal_source: "OHSU News + Health.com (convergent nutrition/metabolism coverage)"
  tools_unavailable: ["Reddit", "X/Twitter social search"]
  notes: "Recall and mental-health themes have now appeared in 5+ consecutive runs (10/06–10/10) with today's radar reconfirming the same stories — flag as 'recurring, check for staleness' rather than re-scoring as new. Two otherwise-interesting science stories (USC psilocybin trial, Stanford microbiome study) were held to Monitor status purely on single-source sourcing — both are candidates to re-check in 48–72h if wire/major-outlet pickup occurs."
```

---

## 4. Skill 02b — Health Claim Verification Gate: Routing Summary

| Topic | Risk Type | Primary Source Found | Gate Result | Notes |
|---|---|---|---|---|
| Late-night eating & liver study | study_or_research | Yes (OHSU institutional release, named researchers) | **Pass** | Mild, appropriately hedged framing ("may be bad") |
| GLP-1 mechanism/side-effects explainer | drug_or_treatment_claim | Yes (FDA labeling + established STEP/SURMOUNT trial literature) | **Pass** | Well-documented mechanism, no novel/unverified claims |
| USC psilocybin + mindfulness depression trial | clinical_trial | Yes (Keck School of Medicine institutional release) | **Pass** (routed to Monitor at Skill 04 for sourcing thinness, not a gate failure) | Trial is enrollment-stage — integrity flag required on efficacy framing |
| Stanford gut microbiome / migration study | study_or_research | Yes (Stanford Medicine institutional release) | **Pass** (routed to Monitor at Skill 04) | Same single-source limitation |
| Baby/infant sleep aid recall (undisclosed alcohol) | recall | No — single low-tier source, no lot codes, no FDA.gov hit | **Reject** | Breaking-recall exception requires 3+ sources; only 1 found |
| Diet soda / weight-management "study" (Trends query) | study_or_research | No primary source located in any channel | **Reject** | Unverifiable health claim |

---

## 5. Final Editorial Priority Board

```yaml
priority_board:
  - priority_level: P2
    publish_timing: short_term
    topic: "New study links late-night eating to liver strain and metabolic disruption"
    primary_entity: "OHSU late-night eating / liver health study"
    signal_type: study_or_research
    allowed_category: "nutrition and diet science"
    trend_strength_score: 58
    opportunity_score: 62
    discover_score: 4
    urgency: this_week
    confidence: medium
    content_status: new
    source_count: 2
    recommended_angle: "Does when you eat matter more than what you eat? New OHSU research reframes 'best time for dinner' advice with liver-health data."
    why_now: "Fresh OHSU research (10/09) directly updates widely-searched 'best time to eat dinner' evergreen content with new liver/metabolism evidence."
    primary_headline: "New Study Suggests Late-Night Eating May Strain Your Liver — Here's What That Means"
    next_steps: "Assign full brief (below); confirm underlying journal citation via OHSU media contact before publishing."
    notes: "Two-source convergence (OHSU + Health.com); no breaking urgency but strong cluster-expansion fit with existing nutrition content."

  - priority_level: P3
    publish_timing: scheduled
    topic: "How Wegovy and Zepbound actually work — mechanism and side effects explained"
    primary_entity: "GLP-1/GIP receptor agonists (semaglutide, tirzepatide)"
    signal_type: rising_search_interest
    allowed_category: "chronic disease management"
    trend_strength_score: 56
    opportunity_score: 82
    discover_score: 4
    urgency: evergreen
    confidence: medium
    content_status: new
    source_count: 2
    recommended_angle: "Plain-language mechanism + side-effect explainer answering the exact 'explain how X works' queries now trending — positions for AI answer-engine citation."
    why_now: "Google Trends shows a sharp rise in queries phrased as AI-style explain requests ('explain how wegovy works...', 'explain how zepbound works...') — a format gap in existing GLP-1 coverage."
    primary_headline: "How Do Wegovy and Zepbound Actually Work? The Science, Side Effects, and What to Expect"
    next_steps: "Build concise brief (below); schedule as supporting piece in GLP-1 content cluster (links to 10/04 pipeline article)."
    notes: "High opportunity score driven by search-format gap, not news urgency — correctly scheduled rather than fast-tracked."

  - priority_level: P5
    publish_timing: monitor
    topic: "USC launches psilocybin + mindfulness meditation trial for depression"
    primary_entity: "Keck School of Medicine psilocybin/depression clinical trial"
    signal_type: clinical_trial
    allowed_category: "mental health and psychology"
    trend_strength_score: 44
    opportunity_score: 80
    discover_score: null
    urgency: this_week
    confidence: low
    content_status: new
    source_count: 1
    recommended_angle: "N/A — hold for corroboration"
    why_now: "Single-source institutional announcement; high potential interest but insufficient confirmation to score for publication."
    primary_headline: null
    next_steps: "Re-check in 48–72h for wire/major-outlet pickup; re-score if a second independent source confirms."
    notes: "Gate passed (02b); held at Skill 04 for sourcing thinness, not a safety concern. Integrity flag if advanced: trial is enrollment-stage, no efficacy data yet."

  - priority_level: P5
    publish_timing: monitor
    topic: "Stanford study: gut microbiome signatures trace ancient human migration"
    primary_entity: "Stanford Medicine gut microbiome/migration study"
    signal_type: study_or_research
    allowed_category: "gut health and microbiome"
    trend_strength_score: 46
    opportunity_score: 64
    discover_score: null
    urgency: this_week
    confidence: low
    content_status: new
    source_count: 1
    recommended_angle: "N/A — hold for corroboration"
    why_now: "Novel and attention-worthy, but single institutional source with no secondary pickup yet."
    primary_headline: null
    next_steps: "Re-check in 48–72h; this is more anthropology/genomics than actionable health content, so even with corroboration, confirm fit against 'audience would solve a problem / act on it' bar before upgrading."
    notes: "Gate passed (02b). Hold is about sourcing thinness, not claim risk."

summary:
  total_topics: 4
  high_priority_count: 0
  immediate_actions: "None rated P1 today — no breaking, high-confidence, high-urgency health story cleared all gates. Two solid P2/P3 candidates moved to brief; two scientifically interesting stories held at Monitor pending broader confirmation."
pass_to_next_layer: false
```

---

## 6. Editorial Briefs for Retained Candidates

### Brief 1 (P2 — Full Deep-Dive)

```yaml
brief:
  primary_headline: "New Study Suggests Late-Night Eating May Strain Your Liver — Here's What That Means"
  alternate_headlines:
    - "Is Eating Dinner Late Actually Bad for Your Liver? What New Research Shows"
    - "The Hidden Cost of Late-Night Meals: Liver Health, Not Just Weight"
  topic: "Late-night eating and liver/metabolic health"
  primary_entity: "OHSU late-night eating study"
  search_intent: "Evaluative + informational (does meal timing matter / is this true)"
  angle: "Reframe the well-worn 'best time to eat dinner' evergreen topic around new liver-specific findings, directly addressing reader skepticism about whether meal-timing advice is substantiated or folk wisdom."
  why_now: "OHSU research published 10/09 gives a concrete, citable evidence hook to a topic (meal timing/metabolism) already being covered broadly (see Health.com, same week) — timely without being purely trend-chasing."
  integrity_flags:
    - "⚠️ Integrity note: confirm whether this is an observational or interventional study before stating a causal liver-health link — OHSU's own framing ('may be bad') suggests caution is warranted."
    - "⚠️ Integrity note: avoid generalizing any animal-model component of the underlying research to humans without explicit qualification."
  outline:
    intro: "Open with the common evening habit (eating dinner late/snacking at night) and the question of whether it actually matters for health beyond weight."
    sections:
      - "What the OHSU research actually found (liver enzymes, metabolic markers, study design/size)"
      - "How this connects to existing circadian-rhythm and metabolism research (tie to Health.com's meal-timing/sleep piece)"
      - "What registered dietitians/hepatologists say about practical takeaways"
      - "What this doesn't prove yet — observational vs. causal, sample size caveats"
    conclusion: "Practical, non-alarmist takeaway: timing may matter, but it's one factor among many — avoid fear-based framing."
  key_data_points:
    - "OHSU findings on late-night eating and liver markers [confirm exact statistic from source before publishing]"
  source_plan:
    - { publisher: "OHSU News", url: "https://news.ohsu.edu/2026/10/09/late-night-eating-may-be-bad-for-your-liver-study-suggests", tier: 1, used_for: "Primary study coverage" }
    - { publisher: "Health.com", url: "https://www.health.com/when-to-eat-dinner-for-better-metabolism-and-sleep-12162013", tier: 2, used_for: "Context on meal timing and metabolism/sleep" }
  evidence_requirements: "Moderate — cite OHSU findings with specifics (sample size, study type), link underlying journal publication if locatable via OHSU media contact."
  expert_sources:
    - { type: "Hepatologist or circadian-rhythm researcher", name: "Named OHSU study author (pull from press release)", reason: "Direct authority on the study's claims" }
    - { type: "Registered Dietitian Nutritionist", name: "To be sourced from existing published commentary", reason: "Practical, balanced consumer takeaway" }
  internal_links: ["Existing/related: 'best time to eat dinner' content", "GLP-1/metabolism content cluster"]
  visual_brief: "Simple infographic-style graphic: clock face showing 'eating windows' vs. liver/metabolism icons. Avoid fear-based imagery (no distressed-looking people)."
  seo:
    primary_keyword: "late night eating liver health"
    supporting_keywords: ["best time to eat dinner", "meal timing metabolism", "late eating study"]
    format: "Explainer article, ~900–1100 words"
    schema_markup: "Article + MedicalWebPage"
    cluster: "Nutrition & metabolism"
  discover_notes: "Strong AI-citation potential: specific institution (OHSU), clear study hook, maps to natural question 'is eating late bad for your liver.'"
  key_takeaways:
    - "New OHSU research links late-night eating to liver strain markers"
    - "Builds on existing circadian/metabolism research, not a standalone claim"
    - "Practical takeaway: timing is one factor, not a verdict"
  estimated_word_count: "900–1100"
execution_notes: "Confirm underlying journal citation directly from OHSU before publication; do not rely solely on press-release framing for causal language."
confidence: medium
pass_to_next_layer: true
recommended_next_skill: 11_discover_optimizer
```

### Brief 2 (P3 — Concise)

```yaml
brief:
  headline: "How Do Wegovy and Zepbound Actually Work? The Science, Side Effects, and What to Expect"
  topic: "GLP-1/GIP receptor agonist mechanism and side-effect explainer"
  angle: "Answer the exact AI-style 'explain how it works' queries now spiking in search, in plain language, positioning for AI answer-engine citation rather than competing on generic Ozempic-news coverage."
  key_data_points:
    - "Semaglutide (Wegovy) and tirzepatide (Zepbound) mechanisms: GLP-1/GIP receptor agonism, appetite regulation [cite FDA labeling]"
    - "Common side effects per FDA prescribing information (GI effects most common)"
  integrity_flags:
    - "⚠️ Integrity note: cite FDA-approved labeling directly for side-effect prevalence rather than secondary summaries; do not conflate semaglutide and tirzepatide mechanisms as identical."
  expert_type_needed: "Endocrinologist or obesity-medicine physician to confirm mechanism explanation accuracy"
  seo:
    primary_keyword: "how does wegovy work"
    format: "Explainer / FAQ-structured article, ~800–1000 words"
    serp_difficulty: "Medium"
  sources:
    - { publisher: "FDA — Wegovy prescribing information", url: "[URL unverified — confirm via accessdata.fda.gov drug label search]" }
    - { publisher: "FDA — Zepbound prescribing information", url: "[URL unverified — confirm via accessdata.fda.gov drug label search]" }
    - { publisher: "ClinicalTrials.gov — semaglutide/tirzepatide weight-loss trials", url: "https://clinicaltrials.gov/search?term=semaglutide+tirzepatide+weight+loss" }
  estimated_word_count: "800–1000"
```

---

## 7. Rejected Topics Log

| Topic | Reason |
|---|---|
| HHS/CMS healthcare price transparency rule | Off-category — policy/business, no health-evidence angle |
| Gilead × Calm wellness partnership | Off-category — pharma marketing partnership |
| Rutgers opioid-ban op-ed | Off-category — speculative policy opinion |
| World Mental Health Day institutional PR (8 items) | Local/institutional, excluded |
| Lancet/AMIE AI study, NYT AI chatbot triage, Pew influencer studies | Existing — covered 10/07–10/09 |
| Nobel Prize in Medicine | Existing — covered 10/06 |
| Heat/sauna therapy for depression | Existing — covered 10/06 |
| WHO community mental health shift | Existing — covered 10/10 |
| Screwworm/USDA | Existing — covered 10/10 |
| Gatorade recall, eye drop recall | Existing — covered 10/06 and 10/08 |
| Frozen blueberries E. coli investigation | Stale — July 2026 investigation page re-surfacing |
| Baby/infant sleep aid recall | **Rejected at Skill 02b** — unverifiable health claim (single low-tier source, no FDA.gov confirmation) |
| Diet soda/weight-management study (Trends query) | **Rejected at Skill 02b** — unverifiable health claim (no traceable primary source) |
| Celebrity mental health rising searches (Lane Johnson, Stephen A. Smith, James Talarico) | Brand safety — speculative commentary on private individuals |
| Mount Sinai EHR tech, Ochsner AI screening, Alpheus glioblastoma trial PR, UNLV trials PR | Weak signal — press-release-only, operational/B2B framing |

---

## 8. Integrity Flags (Consolidated)

- ⚠️ **Late-night eating/liver study**: confirm observational vs. interventional design before using causal language; do not generalize any animal-model findings to humans without qualification.
- ⚠️ **GLP-1 explainer**: cite FDA labeling directly for side-effect claims; do not conflate semaglutide (Wegovy) and tirzepatide (Zepbound) mechanisms.
- ⚠️ **USC psilocybin trial (Monitor)**: if/when advanced, must be framed as enrollment-stage — no efficacy data exists yet.

---

## 9. Run Notes

- **Thin P1/P2 output is a deliberate outcome, not a gap**: the vast majority of today's Google News Radar volume duplicated stories already covered in the last 5 days (recalls, WHO mental health, Nobel Prize, AI-in-medicine). Per the skeptical-editor mandate, these were rejected rather than re-scored as "new."
- **Two scientifically interesting stories (USC psilocybin trial, Stanford microbiome study)** passed Skill 02b cleanly but were held at Skill 04 purely for single-source sourcing — both are explicit re-check candidates in 48–72h.
- **Recurring themes flagged**: mental health and FDA recalls have each appeared in 5 consecutive runs (10/06–10/10) and recurred again today — worth a staleness review of `GOOGLE_NEWS_QUERIES` per the rejection-trend pattern this system has previously surfaced (off-category and duplicate reasons dominate rejections).
- **No deferred topics** had a passed `recheck_on` date today.
- `site_url` not configured — competitor-list fallback used for SERP-gap/duplicate context per `configs/competitor_list.yaml`.
- Tools unavailable this run: Reddit, X/Twitter social search (not queried) — did not materially affect scoring since all retained/monitored candidates were news/institutional/search-driven, not social-spike signals.